Capital raised by Accipiter Biosciences
1 Form D filing · first filed Jul 2026 · Seattle, WA
Chief Executive Officer
Signatory on Accipiter Biosciences's Form D filings · $10.5M raised across 1
Matthew Bick is on file as Chief Executive Officer at Accipiter Biosciences in Seattle, WA. Accipiter Biosciences has 1 Form D filing on record, $10.5M raised in total. Matthew Bick appears as a signatory on the company's filings.
LinkedIn profileA computational protein design platform that generates entirely new protein sequences, synthesizes and purifies them in the lab, and tests them functionally in cell and animal models, producing single-agent biologics that engage multiple pathways.
